(Q44161643)

30 November 2017

In vitro evaluation of bendamustine induced apoptosis in B-chronic lymphocytic leukemia (English)

1 reference

30 November 2017

1 reference

1 reference

Schwänen C

1

1 reference

30 November 2017

Hecker T

2

1 reference

30 November 2017

Hübinger G

3

1 reference

30 November 2017

Wölfle M

4

1 reference

30 November 2017

Rittgen W

5

1 reference

30 November 2017

Bergmann L

6

1 reference

30 November 2017

Karakas T

7

1 reference

30 November 2017

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

16

1 reference

30 November 2017

2096-2105

1 reference

30 November 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402651

30 November 2017

0 references

cites work

Chronic lymphocytic leukemia: new insights into biology and therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Fludarabine ability to down-regulate Bcl-2 gene product in CD5+ leukaemic B cells: in vitro/in vivo correlations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Dissecting the pathways to death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Caspases: killer proteases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Molecular signals in anti-apoptotic survival pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkin's lymphomas.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

1 reference

7 January 2021

Weekly administration of bendamustine: a phase I study in patients with advanced progressive solid tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Bendamustine as salvage treatment in patients with advanced progressive breast cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

In vitro chemosensitivity of chronic lymphocytic leukaemia to purine analogues--correlation with clinical course.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Induction of apoptosis by 2-chlorodeoxyadenosine in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

The activity of the DNA-dependent protein kinase (DNA-PK) complex is determinant in the cellular response to nitrogen mustards

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Potentiation of antitumor effects of cyclophosphamide derivatives in B-chronic lymphocytic leukemia cells by 2-chloro-2'-deoxyadenosine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Consolidation therapy with high-dose cyclophosphamide improves the quality of response in patients with chronic lymphocytic leukemia treated with fludarabine as induction therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Processing/activation of caspases, -3 and -7 and -8 but not caspase-2, in the induction of apoptosis in B-chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Chlorambucil in chronic lymphocytic leukemia: mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Drug-induced apoptosis in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

The most unkindest cut of all: on the multiple roles of mammalian caspases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Signaling to p53: breaking the MDM2-p53 circuit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402651

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402651

1 reference

30 November 2017

1 reference